Concepedia

Natalia Vostokova

NV

Statistics

Publications

8

Citations

370

H-Index

8

Active since

2014

Affiliations

Chemical Diversity Research Institute(Current)

Skolkovo Foundation

Infectious Clinical Hospital No. 1

ChemDiv (United States)

Hospital at Smolensk Station

Natalia Vostokova is an author at Chemical Diversity Research Institute specializing in pharmacy, antiviral therapeutics, and antiviral therapy.

Publications per year

2014–2021

8

Publications

8

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Andrey A. Ivashchenko, Kirill Dmitriev, Natalia Vostokova et al. · Clinical Infectious Diseases · 2020 · 267 citations · Full text

, , +16

Interim Results of a Phase II/III Multicenter Randomized Clinical Trial of AVIFAVIR in Hospitalized Patients with COVID-19

Andrey A. Ivashchenko, Kirill Dmitriev, Natalia Vostokova et al. · medRxiv · 2020 · 20 citations · Full text

, , +15

5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia

D. S. Burminskiy, George E. Rupchev, T. A. Lepilkina et al. · Journal of Clinical Psychopharmacology · 2017 · 18 citations

, , +17

A multicenter phase II study of the efficacy and safety of quisinostat (an HDAC inhibitor) in combination with paclitaxel and carboplatin chemotherapy (CT) in patients (pts) with recurrent platinum resistant high grade serous epithelial ovarian, primarily peritoneal or fallopian tube carcinoma cancer (OC).

Sergei Tjulandin, M. Fedyanin, Vladimir Vladimirov et al. · Journal of Clinical Oncology · 2017 · 16 citations

, , +17

Discovery of Novel Highly Potent Hepatitis C Virus NS5A Inhibitor (AV4025)

Alexandre V. Ivachtchenko, Oleg D. Mitkin, Pavel Yamanushkin et al. · Journal of Medicinal Chemistry · 2014 · 14 citations · Full text

, , +16

1–5 of 8